Supply of AZ is so limited in the EU that the EU can afford to be more conservative with recommendations; it's not like de facto restricting AZ to 60-75 (common in European countries) actually slows down vaccination, because there isn't enough AZ available to vaccinate that age group anyway; even if all the AZ is dedicated to it it some of that cohort end up getting Pfizer.